About Horizon 3
Horizon 3 is a company based in 's-hertogenbosch (Netherlands). It operates as a Professional Services and Commission-Based. Horizon 3 offers products and services including Innovation Platform.
- Headquarter 's-hertogenbosch, Netherlands
- SectorsTechnology
- Email••••••••
- Website horizon3.nl
Products & Services of Horizon 3
Horizon 3 offers a comprehensive portfolio of products and services, including Innovation Platform.
Support is provided for biobased technology startups scaling.
Similar companies to Horizon 3
10 companies that operate in the same segment as Horizon 3 (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Horizon 3
Horizon 3 is headquartered in 's-hertogenbosch, Netherlands. It is registered at 's-hertogenbosch, Noord-brabant, Netherlands.
Horizon 3 is established as an innovation platform supporting early-stage technostarters in the biobased economy. Focus is placed on bridging the gap between proof of concept and industrial-scale application. Contributions are made to sustainability in food chains, waste reduction, and lowering CO2 footprints of cities and companies. Venture capital, entrepreneurial support, and access to facilities are provided. Collaboration with strategic partners from food, feed, and waste processing industries, as well as government and venture capitalists, is facilitated to foster open innovation and sustainable growth.
Horizon 3 offers Innovation Platform.